Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
2,722,467
-
Shares change
-
+1,131,229
-
Total reported value, excl. options
-
$187,899,411
-
Value change
-
+$79,801,407
-
Put/Call ratio
-
3735%
-
Number of buys
-
18
-
Number of sells
-
-14
-
Price
-
$69.02
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2021
63 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q1 2021.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,722,467 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1,447,127 shares), BANK OF AMERICA CORP /DE/ (525,074 shares), BNP PARIBAS ARBITRAGE, SA (200,000 shares), 20/20 Capital Management, Inc. (112,402 shares), Brinker Capital Investments, LLC (70,000 shares), ROYAL BANK OF CANADA (66,006 shares), Orion Portfolio Solutions, LLC (59,921 shares), CITADEL ADVISORS LLC (57,749 shares), MORGAN STANLEY (32,907 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (21,272 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.